Epidemiology of chronic inflammatory demyelinating polyneuropathy abroad and in Russia

Epidemiology of chronic inflammatory demyelinating polyneuropathy abroad and in Russia

Current article provides an overview of the results of epidemiological studies of chronic inflammatory demyelinating polyneuropathy (CIDP) in Russia and abroad. It is shown that the prevalence of CIDP is different in countries, due to the use of different diagnostic criteria. It should be noted that...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. E. Popova, N. A. Shnayder, M. M. Petrova, T. Ya. Nikolaeva, E. A. Kantimirova
Format:	Article
Language:	Russian
Published:	ABV-press 2015-06-01
Series:	Нервно-мышечные болезни
Subjects:	chronic inflammatory demyelinating polyneuropathy atypical forms epidemiology population prevalence morbidity guillain– barre syndrome herpes viruses diagnostic criteria lewis–sumner syndrome multifocal motor neuropathy
Online Access:	https://nmb.abvpress.ru/jour/article/view/112
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Atypical variants of chronic inflammatory demyelinating polyneuropathy with benign course: a clinical observation for 8 patients without pathogenic therapy
by: D. A. Grishina, et al.
Published: (2020-08-01)

Validation of the Neuropathy Impairment Score (NIS) for use in Russian-speaking patients with chronic inflammatory demyelinating polyneuropathy
by: N. A. Suponeva, et al.
Published: (2024-12-01)

Inflammatory demyelinating polyneuropathies and patient management during the COVID-19 pandemic. Literature review
by: R. Bunevičiūtė, et al.
Published: (2020-06-01)

Diagnostic criteria and therapeutic implications of rapid-onset demyelinating polyneuropathies
by: Wiktoria Rałowska-Gmoch, et al.
Published: (2024-12-01)

Dynamics of the incidence of acute and chronic inflammatory polyneuropathies in adults in the Leningrad region
by: E. A. Skornyakova, et al.
Published: (2021-04-01)

The use of rituximab in the treatment of disimmune polyneuropathy: a description of clinical cases and a literature review
by: V. N. Kiselev, et al.
Published: (2019-07-01)

Conduction block as an electrophysiological phenomenon: a review of the literature
by: S. S. Nikitin, et al.
Published: (2019-04-01)

Guillain-Barre Syndrome in A Patient with Infectious Endocarditis: Clinical Observation and Literature Review
by: E. V. Reznik, et al.
Published: (2025-07-01)

Immunoglobulins in neurological practice: a review of the literature
by: S. S. Nikitin, et al.
Published: (2019-04-01)

Nerve sonography in multifocal motor neuropathy and chronic inflammatory demyelinating polyneuropathy
by: D. S. Druzhinin, et al.
Published: (2016-03-01)

The prognostic value of demyelinating electrophysiologic findings and cerebrospinal fluid protein levels in acute inflammatory demyelinating polyneuropathy
by: Abdulkadir TUNÇ, et al.
Published: (2020-08-01)

Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: A Case Report
by: Gabrielė Jankauskaitė, et al.
Published: (2024-12-01)

A retrospective observational study of clinical and electrophysiological types of Guillain-Barre syndrome from Delhi
by: Deepinder K. Maini, et al.
Published: (2025-06-01)

EXPERIENCE IN THE USE OF PLASMAPHERESIS IN ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY GUILLAIN – BARRE SYNDROME IN THE PATIENT WITH CHRONIC HEPATITIS C VIRUS INFECTION AND TYPE 2 DIABETES MELLITUS
by: V. A. Voinov, et al.
Published: (2018-12-01)

Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases
by: N. M. Tereshchenko, et al.
Published: (2023-04-01)

Guillain-Barré syndrome as an early complication of a new coronavirus infection SARS-CoV-2 (clinical case)
by: K.Yu. Lytvyn, et al.
Published: (2022-09-01)

The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with diabetes mellitus
by: R. A. Gapeshin, et al.
Published: (2020-06-01)

Clinical and diagnostic role of autoantibodies to gangliosides of peripheral nerves: literature review and own expirience
by: N. A. Suponeva
Published: (2015-02-01)

Episodes of Guillain-Barré syndrome associated with the acute phase of HIV-1 infection and with recurrence of viremia
by: Castro Gleusa de, et al.
Published: (2006-01-01)

An auxiliary diagnostic strategy for distinguishing Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy: combining platelet-to-lymphocyte ratio and cerebrospinal fluid interleukin-8 levels
by: Simin Song, et al.
Published: (2025-07-01)

Acute Quadriplegia: An Interesting Case with Etiological and Pathophysiological Disparity
by: Vivek Pal Singh, et al.
Published: (2019-07-01)

Steroids for Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005-03-01)

Lumbosacral motor polyneuropathy
by: S. A. Malmberg, et al.
Published: (2015-02-01)

Acute and chronic dysimmune polyneuropathies in the context of the COVID-19 pandemic: pathogenesis, features of the clinical picture, diagnosis and therapy (literature review)
by: A. E. Khrulev, et al.
Published: (2021-09-01)

Acute Inflammatory Demyelinating Polyneuropathy: a comprehensive literature review
by: Karolina Serwońska, et al.
Published: (2025-03-01)

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center
by: Mohammadali Arami, et al.
Published: (2025-05-01)

Evolving understanding of Guillain-Barré syndrome pathophysiology and the central role of the classical complement pathway in axonal injury
by: Kenneth C. Gorson
Published: (2025-05-01)

Case Report: Guillain–Barré syndrome with three episodes and literature review
by: Ying Wang, et al.
Published: (2025-05-01)

Focal Chronic Inflammatory Demyelinating Polyneuropathy – A Case Report with Clinical Application and Validation of 2021 European Academy of Neurology/Peripheral Nerve Society Criteria
by: Fu Liong Hiew, et al.
Published: (2025-01-01)

The specific features of Guillain–Barré syndrome in Russia: Analysis of 186 cases
by: N. A. Suponeva, et al.
Published: (2015-02-01)

Co-Occurrence of Guillain-Barre Syndrome and Multiple Sclerosis: A Rare Case Report
by: Amr Hassan, et al.
Published: (2021-01-01)

Intravenous high-dose immunotherapy: practical recommendations for use in the treatment of neurological disimmune diseases
by: N. A. Suponeva, et al.
Published: (2015-12-01)

PATHOGENESIS, CLINICAL AND LABORATORY FEATURES OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
by: R. A. Gapeshin, et al.
Published: (2018-12-01)

Comparative analysis of clinical and electroneuromyographic indicators in patients with secondary polyneuropathy
by: Ye. S. Korolyova, et al.
Published: (2012-06-01)

Validation of the Medical Research Council sum score (MRCss) for use in Russian-speaking patients with chronic inflammatory demyelinating polyneuropathy
by: N. A. Suponeva, et al.
Published: (2023-03-01)

Diagnostic transcranial magnetic stimulation in children with acute inflammatory demyelinating polyneuropathy
by: V. B. Voitenkov, et al.
Published: (2016-07-01)

Tuberculous spondylitis mimicking acute inflammatory demyelinating polyneuropathy: a rare presentation
by: N. A. Gajadeera, et al.
Published: (2025-03-01)

Inflammatory Neuropathy Cause and Treatment (INCAT) Scale for the assessment of disability level in patients with chronic inflammatory demyelinating polyneuropathy: linguocultural ratification in Russia
by: А. S. Arestova, et al.
Published: (2021-12-01)

Difficulties of differential diagnosis of polyneuropathy developed after Gam-COVID-Vac vaccination on the background of combined infectious pathology (clinical case)
by: S. D. Chukhno, et al.
Published: (2023-01-01)

Campylobacter jejuni induces autoimmune peripheral neuropathy via Sialoadhesin and Interleukin-4 axes
by: Ankit Malik, et al.
Published: (2022-12-01)